Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 18 submissions in the queue.
posted by martyb on Thursday January 10 2019, @09:03PM   Printer-friendly
from the the-clan-Macleod dept.

The anti-cancer drug dasatnib in combination with quercetin being trialed for safety against lung fibrosis has shown impressive anti-aging results.

Participants in the trial were ~70 years old and suffering from pulmonary fibrosis a debilitating and eventually fatal disease. After the trial, 100% of the study showed improvement

participants were able to walk faster, get up from a chair more quickly and scored better in ability tests.

The benefit is a result of removing 'zombie cells' from the body.

Senescent cells - also known as zombie cells - are not completely dead so are not cleared out by the body, but are too damaged to repair tissue or carry out normal functions. Unable to repair itself or clear out the waste, the body gradually deteriorates.

Previously animal studies have shown that removing these cells reverses the ageing process, extends lifespan, and restores lost youth.

Better yet, it does not sound like a pill every day for the rest of your life sort of thing

“It has a hit-and-run effect,” added Dr Kirkland. “The drug starts working quickly and we would ideally like to be able to give it just once a month.”

Of course increasing the cost 30x should nicely take care of that drawback.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2, Interesting) by Anonymous Coward on Friday January 11 2019, @12:16AM (8 children)

    by Anonymous Coward on Friday January 11 2019, @12:16AM (#784746)

    Here is what goes on.

    1) Every tissue in your body consists of a number of "tissue stem cells" that divide when necessary to replenish the tissue when the functional cells die. One division from a tissue stem cell results in one daughter remaining as the stem cell, and the other going on to migrate where it needs to be. Once there, it will divide and each daughter will divide, etc to generate a population of final functional cells.

    2) There is a certain chance of various errors every cell division of these tissue stem cells. These errors can be genetic (point mutations, chromosomal rearrangements, etc), or just junk like amyloids accumulating, or a mitochondria going bad, whatever. Anything that accumulates.

    3) After these tissue stem cells undergo a certain number of divisions (seems to be ~40-60) from the zygote (fertilized egg), the risk of generating a descendant that is malignant gets too high on average. Thus, with the goal of extending the organisms life the stem cell is supposed to stop dividing and replenishing the tissue.

    4) Because the tissue is not going to be replenished any more, the cells already there need to keep functioning for much longer than when the organism was younger. Eventually, not enough cells will be functioning correctly and you get organ failure.

    So the choice is to
    a) kill the partially functional cells (fast organ failure)
    b) let the tissue stem cells keep dividing (increases the chance of cancer)
    c) leave things as they are with partially functional cells in the tissue (slow organ failure)

    These researchers are choosing choice A.

    Starting Score:    0  points
    Moderation   +2  
       Interesting=2, Total=2
    Extra 'Interesting' Modifier   0  

    Total Score:   2  
  • (Score: 1, Interesting) by Anonymous Coward on Friday January 11 2019, @01:45AM (5 children)

    by Anonymous Coward on Friday January 11 2019, @01:45AM (#784784)

    Or, maybe choice (a) (kill the partially functional cells) leads the tissue stem cells to notice a lack of functional cells and divide a little more to prevent organ failure. Which turns it into choice (b).

    Choice (b) may be the best one these days. We have much better cancer treatments than we used to, so on balance getting cancer may be better than organ failure.

    • (Score: 3, Interesting) by takyon on Friday January 11 2019, @02:25AM (1 child)

      by takyon (881) <takyonNO@SPAMsoylentnews.org> on Friday January 11 2019, @02:25AM (#784812) Journal

      If we can tackle cancer with stuff like nanobots, then we should absolutely choose the option that leads to cancer.

      Basically everyone will get cancer eventually, so it would have to be dealt with at some point regardless of anti-aging strategies.

      --
      [SIG] 10/28/2017: Soylent Upgrade v14 [soylentnews.org]
      • (Score: 3, Insightful) by legont on Friday January 11 2019, @05:27AM

        by legont (4179) on Friday January 11 2019, @05:27AM (#784907)

        Yes. Basically, we convert all the issues into a cancer issue(s) and then deal with them one by one. This is not ideal, but should work. It also has an advantage of being incremental progress as opposed to a revolution.

        --
        "Wealth is the relentless enemy of understanding" - John Kenneth Galbraith.
    • (Score: 0) by Anonymous Coward on Friday January 11 2019, @03:56AM (2 children)

      by Anonymous Coward on Friday January 11 2019, @03:56AM (#784877)

      We have much better cancer treatments than we used to

      Source?

      • (Score: 0) by Anonymous Coward on Friday January 11 2019, @12:48PM (1 child)

        by Anonymous Coward on Friday January 11 2019, @12:48PM (#785001)
        • (Score: 0) by Anonymous Coward on Friday January 11 2019, @03:41PM

          by Anonymous Coward on Friday January 11 2019, @03:41PM (#785066)

          As I expected. You can't really tell from that data, it would be interesting to look further but I'm pretty sure I know what I'll find (various issues with comparing changing populations in the 9% of the US they consider).

          "Population‐based cancer incidence data in the United States have been collected by the National Cancer Institute's (NCI's) Surveillance, Epidemiology, and End Results (SEER) Program since 1973 and by the Centers for Disease Control and Prevention's (CDC's) National Program of Cancer Registries (NPCR) since 1995. The SEER program is the only source for historic population‐based incidence data. Long‐term (1975–2015) incidence and survival trends were based on data from the 9 oldest SEER areas (Connecticut, Hawaii, Iowa, New Mexico, Utah, and the metropolitan areas of Atlanta, Detroit, San Francisco–Oakland, and Seattle–Puget Sound), representing approximately 9% of the US population."

          https://onlinelibrary.wiley.com/doi/full/10.3322/caac.21551 [wiley.com]

          So, looks like the headline chart[1] is only using data from the 9 original SEER regions (Connecticut, Hawaii, Iowa, New Mexico, Utah, and the metropolitan areas of Atlanta, Detroit, San Francisco–Oakland, and Seattle–Puget Sound). Also, some new data source was added in 1995, which is about when we see that peak in incidence/mortality. So we have some room for systematically biasing the data here, especially when we consider the various pitfalls of "age-adjustment".

          They also say much of the mid-1990s spike in incidence for males was due to detection of asymptomatic prostate cancer:

          "Cancer incidence patterns reflect trends in behaviors associated with cancer risk and changes in medical practice, such as the use of cancer screening tests. The volatility in incidence for males reflects rapid changes in prostate cancer incidence rates, which spiked in the late 1980s and early 1990s (Fig. 3) due to a surge in the detection of asymptomatic disease as a result of widespread prostate‐specific antigen (PSA) testing among previously unscreened men"

          [1] https://wol-prod-cdn.literatumonline.com/cms/attachment/479916e1-e899-4965-a35d-7517620064cf/caac21551-fig-0002-m.jp [literatumonline.com]

  • (Score: 3, Informative) by ElizabethGreene on Friday January 11 2019, @04:45PM (1 child)

    by ElizabethGreene (6748) Subscriber Badge on Friday January 11 2019, @04:45PM (#785102) Journal

    You're talking about something different.

    The key points on senescent cells are:
    They are old cells that have become non-functional. They don't perform the function they are designed to do.
    They are functionally immortal, and continue taking up space and resources within the host. Their autolysis mechanism is busted.
    They encourage senescence in their cellular neighborhood.
    Most critically, they cause Inflammation [wikipedia.org]. This is the big problem.

    Normally Inflammation is a good thing. It triggers your self repair mechanisms to come in, clean up an injury, and fix it. This "good" inflammation is called Acute inflammation. The problem with senescent cells is they request repair with nothing to clean up; there is no work to do. That creates systemic or chronic inflammation. Chronic inflammation is a DOT debuff. (DOT=Damage over Time [webopedia.com]) The more senescent cells you have the more DOTs you carry.

    The working hypothesis is that killing off and cleaning out the senescent cells will reduce the overall level of systemic/chronic inflammation and let the body's own self-repair mechanisms step back in to fix real problems.

    • (Score: 0) by Anonymous Coward on Saturday January 12 2019, @05:41AM

      by Anonymous Coward on Saturday January 12 2019, @05:41AM (#785412)

      They are old cells that have become non-functional. They don't perform the function they are designed to do.

      Thats not the definition: https://en.m.wikipedia.org/wiki/Cellular_senescence [wikipedia.org]